TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Merck Life Science AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,288,447
|
1,322,751
|
929,235 |
Financial expenses |
0
|
1,225
|
30 |
Earnings before taxes |
700,894
|
711,031
|
617,209 |
EBITDA |
662,195
|
707,339
|
617,130 |
Total assets |
1,436,153
|
917,612
|
577,076 |
Current assets |
1,422,316
|
902,830
|
501,419 |
Current liabilities |
95,888
|
133,124
|
67,453 |
Equity capital |
1,329,474
|
773,679
|
503,607 |
- share capital |
10,300
![]() |
10,300
![]() |
10,300 |
Employees (average) |
48
|
46
|
29 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
92.6%
|
84.3%
|
87.3% |
Turnover per employee |
26,843
|
28,755
|
32,043 |
Profit as a percentage of turnover |
54.4%
|
53.8%
|
66.4% |
Return on assets (ROA) |
48.8%
|
77.6%
|
107.0% |
Current ratio |
1483.3%
|
678.2%
|
743.4% |
Return on equity (ROE) |
52.7%
|
91.9%
|
122.6% |
Change turnover |
-34,304
|
393,516
|
183,141 |
Change turnover % |
-3%
|
42%
|
25% |
Chg. No. of employees |
2
|
17
|
0 |
Chg. No. of employees % |
4%
|
59%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.